News
-
-
-
-
PRESS RELEASE
Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
Applied DNA Sciences, Inc. undergoes workforce reduction to focus on LineaRx synthetic DNA manufacturing. Ceases operations at Applied DNA Clinical Labs. Strategic decisions for growth and operational efficiency -
-
-
-
PRESS RELEASE
Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
Initial proof-of-concept results show crofelemer's efficacy in reducing TPN for intestinal failure patients. Jaguar seeking partnerships for drug development and commercialization -
-